In vitro studies on human adipocytes and serum showed that elevated RBP4 levels in morbidly obese patients may promote insulin resistance through lipolysis and macrophage activation causing a pro-inflammatory cytokine release [23]. Here, RBP4 is linked to Insulin resistance.